Kera Capital Partners Inc. increased its position in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) by 347.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,556 shares of the company’s stock after buying an additional 12,859 shares during the period. Kera Capital Partners Inc.’s holdings in Docusign were worth $1,132,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Central Pacific Bank Trust Division purchased a new stake in Docusign in the fourth quarter worth about $25,000. Modus Advisors LLC purchased a new position in Docusign during the 4th quarter valued at about $27,000. Torren Management LLC bought a new stake in shares of Docusign in the 4th quarter valued at about $28,000. True Wealth Design LLC raised its holdings in shares of Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after purchasing an additional 222 shares in the last quarter. Finally, Aventura Private Wealth LLC purchased a new stake in shares of Docusign in the 4th quarter worth approximately $30,000. 77.64% of the stock is currently owned by institutional investors.
Insider Transactions at Docusign
In other Docusign news, Director Mary Agnes Wilderotter sold 3,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $48.15, for a total transaction of $144,450.00. Following the sale, the director owned 59,803 shares in the company, valued at approximately $2,879,514.45. The trade was a 4.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $46.83, for a total value of $561,960.00. Following the completion of the transaction, the insider directly owned 53,631 shares in the company, valued at $2,511,539.73. This represents a 18.28% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 48,793 shares of company stock worth $2,322,737. Insiders own 0.59% of the company’s stock.
Docusign Price Performance
Docusign (NASDAQ:DOCU – Get Free Report) last released its quarterly earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $0.99 by $0.10. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The company had revenue of $830.24 million during the quarter, compared to analysts’ expectations of $824.71 million. During the same period last year, the business posted $0.90 earnings per share. The firm’s revenue was up 8.7% compared to the same quarter last year. As a group, equities research analysts anticipate that Docusign Inc. will post 1.97 earnings per share for the current year.
Docusign declared that its Board of Directors has authorized a stock buyback program on Tuesday, March 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 21% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s management believes its shares are undervalued.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a research note on Friday, June 5th. UBS Group set a $60.00 price objective on shares of Docusign in a research note on Friday, June 5th. Citizens Jmp lowered their target price on Docusign from $124.00 to $86.00 and set a “market outperform” rating for the company in a report on Wednesday, March 18th. Citigroup increased their target price on Docusign from $50.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, June 5th. Finally, Royal Bank Of Canada cut their price target on Docusign from $70.00 to $55.00 and set a “sector perform” rating on the stock in a report on Wednesday, March 18th. Three research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $60.27.
Get Our Latest Report on Docusign
Docusign Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Featured Stories
- Five stocks we like better than Docusign
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
